Monoclonal Antibody Therapy is a form of Immunotherapy that uses monoclonal antibodies (mAb) to bind mono-specifically to certain cells or proteins. This may then stimulate the patient’s immune system to attack those cells.
Monoclonal Antibodies are laboratory-produced versions of immune system proteins that have been engineered to serve as substitute antibodies that can restore, enhance or mimic the immune system’s attack on cancer cells.
Antibodies can be very useful in treating cancer because they can be designed to attack a very specific part of a cancer cell. Monoclonal antibody drugs enlist natural immune system functions to fight cancer. These drugs may be used in combination with other cancer treatments.